Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
307 participants
OBSERVATIONAL
2011-06-30
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Mindfulness Meditation on Fibromyalgia-Related Pain
NCT02581332
Impact of a Specific Training Program on the Neuromodulation of Pain in Fibromyalgia Subjects
NCT02486965
Pain Neuroscience Education, Conditioned Pain Modulation and Emotional Processes in Fibromyalgia
NCT07055971
A Study of the Effect of Rhythmic Sensory Stimulation on Fibromyalgia
NCT02493348
Pain Phenotypes in Patients with Fibromyalgia Syndrome
NCT05941780
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Back Pain
Individuals who experience bothersome low back pain.
No interventions assigned to this group
Headache
Individuals who experience bothersome headaches.
No interventions assigned to this group
Fibromyalgia
Individuals who experience bothersome fibromyalgia-related pain.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years of age;
* Confirms a diagnosis from a physician or certified medical provider of one of the three medical conditions (low back pain, headache, fibromyalgia), and that pain related to this diagnosis is still bothersome.
* Has experienced bothersome pain associated with their diagnosis in the past three months of a sufficient intensity;
* English is their first and primary language.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Jensen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark P Jensen, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Washington
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jensen MP, Johnson LE, Gertz KJ, Galer BS, Gammaitoni AR. The words patients use to describe chronic pain: implications for measuring pain quality. Pain. 2013 Dec;154(12):2722-2728. doi: 10.1016/j.pain.2013.08.003. Epub 2013 Aug 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
40324-EA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.